Further research is needed to detect the tumor-infiltrating immune cell populations and cytokines in an orthotopic mouse HCC model with CEP192 inhibition, which will provide definitive evidence for the immunosuppressive role of CEP192 in HCC. The gene discussed is CEP192; the disease is hepatocellular carcinoma.